ARTICLE | Company News
InteRNA Technologies, Silence Therapeutics deal
September 19, 2011 7:00 AM UTC
The companies partnered to develop microRNA therapeutics to treat cancer. InteRNA will provide specific miRNA sequences which Silence will formulate with its AtuPLEX delivery system to develop multiple drug candidates. The partners will conduct preclinical studies before selecting lead candidates. Silence is eligible to receive upfront payments plus milestones. Details were not disclosed. ...